Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Eli Lilly recently announced plans to sell cheaper ... the only options when it comes to weight loss or diabetes, and significantly more affordable FDA-approved options do exist.

Lilly recently announced plans to sell cheaper ... not the only options when it comes to weight loss or diabetes, and signficantly more affordable FDA-approved options do exist.

Hims outright bought its own 503B compounding pharmacy earlier this year, a sign of the tech world’s plans ... to weight loss or diabetes, and signficantly more affordable FDA-approved options ...